CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
October 25, 2022
RhythMedix Expands Monitoring Capabilities of Its RhythmStar System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity
October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms,…
Read More
Asher Kimchi, MD: 1946-2022
October 24, 2022
Founder, Medical Co-Director of Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute Remembered
October 24, 2022 — Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine,…
Read More
CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
October 24, 2022
CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research
October 24, 2022 — CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly…
Read More
Donald Baril, MD, a Leading Vascular Surgeon in the Smidt Heart Institute, Named Director of the Vascular Surgery Fellowship Program
October 24, 2022
Vascular Surgeon to Lead, Train Fellows
October 24, 2022 The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as…
Read More
Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated announced submission of pivotal clinical data from the AcQForce Flutter trial
October 24, 2022
Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter and System
October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac…
Read More
Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps.
October 21, 2022
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure
October 21, 2022 —  Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-…
Read More
Medtronic “Conduction System Pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates
October 21, 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
October 21, 2022 —  Medtronic plc, a global leader in healthcare technology, today announced it has received U.S. Food…
Read More
A composite photo demonstrating how mixed reality visualization would be combined with robotic surgery in an MRI.
October 20, 2022
Mixed-Reality Robotic Heart Surgery Inside an MRI?
October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National…
Read More
The American Heart Association to enable a wide range of research with real-time data from acute care hospitals
October 20, 2022
New Data Registry Collects Evidence in Cardiogenic Shock Patients
October 20, 2022 — Cardiogenic shock—a life threatening condition when a person’s heart can’t pump enough blood to meet…
Read More
MedAtlas CV will transform cardiovascular care delivery and expand patient access
October 20, 2022
Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV
October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers…
Read More
After dedicating the last 28 years to building one of the world’s leading cardiovascular centers, Dr. Fuster will continue to advance the clinical care, research, and innovative training at Mount Sinai Heart. Image courtesy of Mount Sinai Health System
October 19, 2022
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart
October 19, 2022 — Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named…
Read More
Issuance of new reimbursement-related codes expected to accelerate the use and adoption of ECG-based cardiac dysfunction AI algorithms, including HeartSciences’ MyoVista
October 19, 2022
HeartSciences Announces Major Milestone with the Issuance of CPT Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction
October 19, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences, a medical technology company focused on saving…
Read More
For men and women, the risk factors for cardiovascular disease are largely the same, an extensive global study involving University of Gothenburg researchers shows.
October 19, 2022
Cardiovascular Disease Risks the Same in Both Sexes
October 19, 2022 — For men and women, the risk factors for cardiovascular disease are largely the same, an extensive…
Read More
HeartFlow is the first and only company to provide non-invasive anatomy, physiology, and plaque information based on coronary computed tomography angiography (CCTA)
October 18, 2022
HeartFlow Receives FDA 510(k) Clearance for its Plaque Analysis and RoadMap Analysis
October 18, 2022 —  HeartFlow, Inc., a leader in revolutionizing precision heart care, has received U.S. Food and Drug…
Read More
Gregory D. Casciaro
October 18, 2022
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer
October 18, 2022 —  Foldax, Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive…
Read More
Abiomed’s 14 Fr Impella Low Profile Sheath and dilator set.
October 18, 2022
U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath
October 18, 2022 —  The United States Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for…
Read More
Medtronic conducted a recall to inform health care providers and patients of battery performance issues.
October 18, 2022
FDA Provides Update on Medtronic's HeartWare Ventricular Assist Device (HVAD) System
October 18, 2022 — The U.S. Food and Drug Administration (FDA) is providing updates to the FDA website to include…
Read More
MedAlliance to be Acquired by Cordis
October 18, 2022
MedAlliance to be Acquired by Cordis
October 18, 2022 — Swiss-based medical technology company MedAlliance has announced it has entered into an agreement…
Read More
Significant findings from the highly-anticipated EPIC-STEMI study were presented during a late-breaking scientific session at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2022 Annual Symposium in Boston, MA.
Christine Book
October 17, 2022
Dramatic Cholesterol Reduction from PCSK9 Inhibitor Achieved in EPIC-STEMI Trial
October 17, 2022 — Significant findings from the highly-anticipated EPIC-STEMI study were presented during a late-…
Read More
People with cardiovascular disease still have a high burden of risk factors for severe COVID
October 17, 2022
Smoking, Diabetes and Obesity - Not Preexisting Heart Disease - Bigger Risk of COVID-19 Death, Study Finds
October 17, 2022 —  A national study suggests that risk factors for cardiovascular disease, such as age, smoking and…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now